Page 1419 - Clinical Small Animal Internal Medicine
P. 1419

154  Nonmelanoma Skin Cancers  1357

               with receptor tyrosine kinase inhibitors, to inhibit nor­  setting, and results are generally anecdotal and not
  VetBooks.ir  mal stromal cells that support neoplastic growth. Little   well  documented. Cisplatin, carboplatin, bleomycin,
                                                                  actinomycin D, and mitoxantrone have all been used
               information is currently available about the use of daily,
               low‐dose combination metronomic chemotherapy in
                                                                    literature. Local drug delivery enhanced by electro­
               canine and feline skin or ear canal tumors.        sporadically, with modest response rates noted in the
                 Papilloma lesions may be addressed through the crea­  chemotherapy may increase the local efficacy of these
               tion of an autologous vaccine. This approach is best used     cytotoxic agents.
               in dogs with multicentric papillomas, as is sometimes
               seen in dogs that have been heavily immunosuppressed
               in the transplant or autoimmune disease setting, or in     Prognosis
               dogs with immunosuppression from T‐zone lymphoma.
               In this approach, 1–3 g of papilloma tissue are harvested   The prognosis for patients with localized tumors of the
               from the dog and macerated in a tissue grinder or mortar   skin, adnexal structures, or ear canals is generally highly
               and pestle along with 10 mL of sterile 0.9% saline. To this   favorable. Many lesions are benign and early detection is
               mixture is added 1 mL of neutral buffered formalin,   possible because of the superficial location of the tumors,
               which inactivates live virus as well as altering the struc­  and ear canal tumors are frequently localized to within
               ture of viral oncoproteins to facilitate immune recogni­  the cartilaginous structures of the ear canal, which facili­
               tion. The mixture is refrigerated for three days, and then   tates complete resection. Thus, most dogs and cats
               sieved through sterile cheesecloth or a large‐gauge filter   affected by skin or ear canal tumors are cured by surgical
               to remove residual particulate material. The resultant   excision alone. Exceptions are noted in cases of malig­
               autologous vaccine can be stored in the refrigerator in   nant skin neoplasia, particularly when metastasis to
               1 mL sterile aliquots for future treatment. An immune   nodes  or  distant  sites  is  observed.  Radiation  therapy
               adjuvant such as Immunocidin®  (Corynebacterium    can  be  helpful for large  or  nodally  involved  lesions,
                 parvum derivative), squalene, or BCG is added before   as described earlier.
               injection into the residual papilloma lesions. This treat­  The most common aggressive skin tumors discussed
               ment can be repeated at weekly intervals until lesion   here are squamous cell carcinomas, which have median
               regression is noted. There is no literature regarding use   survivals of 1–2 years with aggressive surgery and/or
               of commercial papillomavirus‐preventive vaccines in the   radiation therapy in both dogs and cats. The exception to
               therapeutic setting.                               this observed survival rate is in the case of nasal planum
                 Systemic chemotherapy or local electrochemotherapy   squamous cell carcinomas in dogs, which are both locally
               has been attempted for aggressive or metastatic dermal   aggressive and metastatic to regional nodes, and have a
               carcinomas. Relatively few agents have been used in this   poorer overall outcome despite aggressive therapy.



                 Further Reading

               Gross TL, Ihrke PJ, Walder EJ, Affolter VK. Section Two:   Munday JS, Kiupel M. Papillomavirus‐associated
                 Neoplasms and Other Tumors. In: Skin Diseases of the   cutaneous neoplasia in mammals. Vet Pathol 2010;
                 Dog and Cat: Clinical and Histopathologic Diagnosis,   47(2): 254–64.
                 2nd edn. Ames, IA: Blackwell Science, 2005, pp.   Vilar‐Saavedra P, Kitchell BE. Sunlight‐induced skin cancer
                 561–689.                                           in companion animals. In: Baldi A, Pasquali P, Spugnini
               Hauck ML. Tumors of the skin and subcutanous tissues.   E, eds. Skin Cancer: A Practical Approach. New York:
                 In: Withrow SJ, Vail DM, Page R, eds. Withrow and   Humana Press, Springer Science+Business Media, 2013,
                 MacEwen’s Small Animal Clinical Oncology, 5th edn.   pp. 499–513.
                 St Louis, MO: Elsevier Saunders, 2012, pp. 305–20.  Villamil JA, Henry CJ, Bryan JN, et al. Identification of the
               Lascelles BD, Parry AT, Stidworthy MF, Dobson JM, White   most common cutaneous neoplasms in dogs and
                 RA. Squamous cell carcinoma of the nasal planum in   evaluation of breed and age distributions for selected
                 17 dogs. Vet Rec 2000; 147(17): 473–6.             neoplasms. J Am Vet Med Assoc 2011; 239(7): 960–5.
   1414   1415   1416   1417   1418   1419   1420   1421   1422   1423   1424